메뉴 건너뛰기




Volumn 271, Issue 5, 2012, Pages 421-428

Innate immune dysfunction in inflammatory bowel disease

Author keywords

Bacteria; Barrier; Defensins; Inflammatory bowel disease; Mucus

Indexed keywords

ALPHA DEFENSIN; AZATHIOPRINE; BETA DEFENSIN; DEFENSIN; METHOTREXATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYPEPTIDE ANTIBIOTIC AGENT; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

EID: 84860241737     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2012.02515.x     Document Type: Review
Times cited : (127)

References (90)
  • 1
    • 33846138032 scopus 로고    scopus 로고
    • The role of microbes in Crohn's disease
    • Eckburg PB, Relman DA. The role of microbes in Crohn's disease. Clin Infect Dis 2007; 44: 256-62.
    • (2007) Clin Infect Dis , vol.44 , pp. 256-262
    • Eckburg, P.B.1    Relman, D.A.2
  • 2
    • 0037043658 scopus 로고    scopus 로고
    • Inflammatory bowel disease
    • Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-29.
    • (2002) N Engl J Med , vol.347 , pp. 417-429
    • Podolsky, D.K.1
  • 3
    • 38649115342 scopus 로고    scopus 로고
    • Microbial influences in inflammatory bowel diseases
    • Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-94.
    • (2008) Gastroenterology , vol.134 , pp. 577-594
    • Sartor, R.B.1
  • 4
    • 0025887076 scopus 로고
    • Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
    • Rutgeerts P, Goboes K, Peeters M et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991; 338: 771-4.
    • (1991) Lancet , vol.338 , pp. 771-774
    • Rutgeerts, P.1    Goboes, K.2    Peeters, M.3
  • 5
    • 0031915148 scopus 로고    scopus 로고
    • Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
    • D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998; 114: 262-7.
    • (1998) Gastroenterology , vol.114 , pp. 262-267
    • D'Haens, G.R.1    Geboes, K.2    Peeters, M.3    Baert, F.4    Penninckx, F.5    Rutgeerts, P.6
  • 6
    • 0026688770 scopus 로고
    • Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance
    • Giaffer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 1992; 33: 1071-5.
    • (1992) Gut , vol.33 , pp. 1071-1075
    • Giaffer, M.H.1    Clark, A.2    Holdsworth, C.D.3
  • 7
    • 0032982463 scopus 로고    scopus 로고
    • T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans
    • Duchmann R, May E, Heike M, Knolle P, Neurath M, Meyer zum Buschenfelde KH. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans. Gut 1999; 44: 812-8.
    • (1999) Gut , vol.44 , pp. 812-818
    • Duchmann, R.1    May, E.2    Heike, M.3    Knolle, P.4    Neurath, M.5    Meyer zum Buschenfelde, K.H.6
  • 8
    • 79953781975 scopus 로고    scopus 로고
    • Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis
    • Khan KJ, Ullman TA, Ford AC et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 2011; 106: 661-73.
    • (2011) Am J Gastroenterol , vol.106 , pp. 661-673
    • Khan, K.J.1    Ullman, T.A.2    Ford, A.C.3
  • 9
    • 33747050143 scopus 로고    scopus 로고
    • The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients
    • Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006; 55: 1141-9.
    • (2006) J Med Microbiol , vol.55 , pp. 1141-1149
    • Bibiloni, R.1    Mangold, M.2    Madsen, K.L.3    Fedorak, R.N.4    Tannock, G.W.5
  • 10
    • 79955554300 scopus 로고    scopus 로고
    • The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases
    • Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1720-8.
    • (2011) Gastroenterology , vol.140 , pp. 1720-1728
    • Chassaing, B.1    Darfeuille-Michaud, A.2
  • 11
    • 35348857386 scopus 로고    scopus 로고
    • Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
    • Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104: 13780-5.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 13780-13785
    • Frank, D.N.1    St Amand, A.L.2    Feldman, R.A.3    Boedeker, E.C.4    Harpaz, N.5    Pace, N.R.6
  • 12
    • 0031758230 scopus 로고    scopus 로고
    • Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease
    • Darfeuille-Michaud A, Neut C, Barnich N et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115: 1405-13.
    • (1998) Gastroenterology , vol.115 , pp. 1405-1413
    • Darfeuille-Michaud, A.1    Neut, C.2    Barnich, N.3
  • 13
    • 22144476548 scopus 로고    scopus 로고
    • Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease
    • Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005; 43: 3380-9.
    • (2005) J Clin Microbiol , vol.43 , pp. 3380-3389
    • Swidsinski, A.1    Weber, J.2    Loening-Baucke, V.3    Hale, L.P.4    Lochs, H.5
  • 14
    • 34047167850 scopus 로고    scopus 로고
    • Comparative study of the intestinal mucus barrier in normal and inflamed colon
    • Swidsinski A, Loening-Baucke V, Theissig F et al. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 2007; 56: 343-50.
    • (2007) Gut , vol.56 , pp. 343-350
    • Swidsinski, A.1    Loening-Baucke, V.2    Theissig, F.3
  • 15
    • 78149283854 scopus 로고    scopus 로고
    • Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria
    • Png CW, Linden SK, Gilshenan KS et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 2010; 105: 2420-8.
    • (2010) Am J Gastroenterol , vol.105 , pp. 2420-2428
    • Png, C.W.1    Linden, S.K.2    Gilshenan, K.S.3
  • 16
    • 77957047689 scopus 로고    scopus 로고
    • Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum
    • Biswas A, Liu YJ, Hao L et al. Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A 2010; 107: 14739-44.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 14739-14744
    • Biswas, A.1    Liu, Y.J.2    Hao, L.3
  • 17
    • 80052580369 scopus 로고    scopus 로고
    • Nod2 is essential for temporal development of intestinal microbial communities
    • Rehman A, Sina C, Gavrilova O et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011; 60: 1354-62.
    • (2011) Gut , vol.60 , pp. 1354-1362
    • Rehman, A.1    Sina, C.2    Gavrilova, O.3
  • 18
    • 32944464648 scopus 로고    scopus 로고
    • Pathogen recognition and innate immunity
    • Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
    • (2006) Cell , vol.124 , pp. 783-801
    • Akira, S.1    Uematsu, S.2    Takeuchi, O.3
  • 19
    • 34548457793 scopus 로고    scopus 로고
    • NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease
    • Peyrin-Biroulet L, Chamaillard M. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. J Endotoxin Res 2007; 13: 135-9.
    • (2007) J Endotoxin Res , vol.13 , pp. 135-139
    • Peyrin-Biroulet, L.1    Chamaillard, M.2
  • 20
    • 0035978651 scopus 로고    scopus 로고
    • Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
    • Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
    • (2001) Nature , vol.411 , pp. 599-603
    • Hugot, J.P.1    Chamaillard, M.2    Zouali, H.3
  • 21
    • 0035978533 scopus 로고    scopus 로고
    • A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
    • Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-6.
    • (2001) Nature , vol.411 , pp. 603-606
    • Ogura, Y.1    Bonen, D.K.2    Inohara, N.3
  • 22
    • 0036202885 scopus 로고    scopus 로고
    • The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease
    • Cuthbert AP, Fisher SA, Mirza MM et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122: 867-74.
    • (2002) Gastroenterology , vol.122 , pp. 867-874
    • Cuthbert, A.P.1    Fisher, S.A.2    Mirza, M.M.3
  • 23
    • 0142180157 scopus 로고    scopus 로고
    • Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2
    • Girardin SE, Travassos LH, Herve M et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 2003; 278: 41702-8.
    • (2003) J Biol Chem , vol.278 , pp. 41702-41708
    • Girardin, S.E.1    Travassos, L.H.2    Herve, M.3
  • 24
    • 0037458665 scopus 로고    scopus 로고
    • Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease
    • Inohara N, Ogura Y, Fontalba A et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003; 278: 5509-12.
    • (2003) J Biol Chem , vol.278 , pp. 5509-5512
    • Inohara, N.1    Ogura, Y.2    Fontalba, A.3
  • 25
    • 77956289824 scopus 로고    scopus 로고
    • Toll-like receptors in inflammatory bowel diseases: a decade later
    • Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis 2010; 16: 1583-97.
    • (2010) Inflamm Bowel Dis , vol.16 , pp. 1583-1597
    • Cario, E.1
  • 27
    • 0034445697 scopus 로고    scopus 로고
    • Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease
    • Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68: 7010-7.
    • (2000) Infect Immun , vol.68 , pp. 7010-7017
    • Cario, E.1    Podolsky, D.K.2
  • 28
    • 6344225825 scopus 로고    scopus 로고
    • Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells
    • Vora P, Youdim A, Thomas LS et al. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol 2004; 173: 5398-405.
    • (2004) J Immunol , vol.173 , pp. 5398-5405
    • Vora, P.1    Youdim, A.2    Thomas, L.S.3
  • 29
    • 33644849605 scopus 로고    scopus 로고
    • NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2
    • Voss E, Wehkamp J, Wehkamp K, Stange EF, Schroder JM, Harder J. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 2006; 281: 2005-11.
    • (2006) J Biol Chem , vol.281 , pp. 2005-2011
    • Voss, E.1    Wehkamp, J.2    Wehkamp, K.3    Stange, E.F.4    Schroder, J.M.5    Harder, J.6
  • 30
    • 7244257312 scopus 로고    scopus 로고
    • NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression
    • Wehkamp J, Harder J, Weichenthal M et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004; 53: 1658-64.
    • (2004) Gut , vol.53 , pp. 1658-1664
    • Wehkamp, J.1    Harder, J.2    Weichenthal, M.3
  • 32
    • 77957586284 scopus 로고    scopus 로고
    • Intestinal epithelial cells in inflammatory bowel diseases
    • Roda G, Sartini A, Zambon E et al. Intestinal epithelial cells in inflammatory bowel diseases. World J Gastroenterol 2010; 16: 4264-71.
    • (2010) World J Gastroenterol , vol.16 , pp. 4264-4271
    • Roda, G.1    Sartini, A.2    Zambon, E.3
  • 33
    • 0030569343 scopus 로고    scopus 로고
    • Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells
    • Zhao C, Wang I, Lehrer RI. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396: 319-22.
    • (1996) FEBS Lett , vol.396 , pp. 319-322
    • Zhao, C.1    Wang, I.2    Lehrer, R.I.3
  • 34
    • 0037165196 scopus 로고    scopus 로고
    • Antimicrobial peptides of multicellular organisms
    • Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-95.
    • (2002) Nature , vol.415 , pp. 389-395
    • Zasloff, M.1
  • 35
    • 1042267410 scopus 로고    scopus 로고
    • Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?
    • Papo N, Shai Y. Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? Peptides 2003; 24: 1693-703.
    • (2003) Peptides , vol.24 , pp. 1693-1703
    • Papo, N.1    Shai, Y.2
  • 37
    • 1842453218 scopus 로고    scopus 로고
    • Defensin-mediated innate immunity in the small intestine
    • Ouellette AJ. Defensin-mediated innate immunity in the small intestine. Best Pract Res Clin Gastroenterol 2004; 18: 405-19.
    • (2004) Best Pract Res Clin Gastroenterol , vol.18 , pp. 405-419
    • Ouellette, A.J.1
  • 38
    • 0033865538 scopus 로고    scopus 로고
    • Differential expression of human alpha- and beta-defensins mRNA in gastrointestinal epithelia
    • Frye M, Bargon J, Lembcke B, Wagner TO, Gropp R. Differential expression of human alpha- and beta-defensins mRNA in gastrointestinal epithelia. Eur J Clin Invest 2000; 30: 695-701.
    • (2000) Eur J Clin Invest , vol.30 , pp. 695-701
    • Frye, M.1    Bargon, J.2    Lembcke, B.3    Wagner, T.O.4    Gropp, R.5
  • 40
    • 44149126798 scopus 로고    scopus 로고
    • Secreted enteric antimicrobial activity localises to the mucus surface layer
    • Meyer-Hoffert U, Hornef MW, Henriques-Normark B et al. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 2008; 57: 764-71.
    • (2008) Gut , vol.57 , pp. 764-771
    • Meyer-Hoffert, U.1    Hornef, M.W.2    Henriques-Normark, B.3
  • 42
    • 29144483937 scopus 로고    scopus 로고
    • Reduced Paneth cell alpha-defensins in ileal Crohn's disease
    • Wehkamp J, Salzman NH, Porter E et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 2005; 102: 18129-34.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 18129-18134
    • Wehkamp, J.1    Salzman, N.H.2    Porter, E.3
  • 43
    • 0037417311 scopus 로고    scopus 로고
    • Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin
    • Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003; 422: 522-6.
    • (2003) Nature , vol.422 , pp. 522-526
    • Salzman, N.H.1    Ghosh, D.2    Huttner, K.M.3    Paterson, Y.4    Bevins, C.L.5
  • 44
    • 46349102893 scopus 로고    scopus 로고
    • Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease
    • Simms LA, Doecke JD, Walsh MD, Huang N, Fowler EV, Radford-Smith GL. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 2008; 57: 903-10.
    • (2008) Gut , vol.57 , pp. 903-910
    • Simms, L.A.1    Doecke, J.D.2    Walsh, M.D.3    Huang, N.4    Fowler, E.V.5    Radford-Smith, G.L.6
  • 45
    • 40449103288 scopus 로고    scopus 로고
    • Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin
    • Elphick D, Liddell S, Mahida YR. Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin. Am J Pathol 2008; 172: 702-13.
    • (2008) Am J Pathol , vol.172 , pp. 702-713
    • Elphick, D.1    Liddell, S.2    Mahida, Y.R.3
  • 46
    • 0842308743 scopus 로고    scopus 로고
    • Paneth cell granule depletion in the human small intestine under infective and nutritional stress
    • Kelly P, Feakins R, Domizio P et al. Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clin Exp Immunol 2004; 135: 303-9.
    • (2004) Clin Exp Immunol , vol.135 , pp. 303-309
    • Kelly, P.1    Feakins, R.2    Domizio, P.3
  • 47
    • 13244292161 scopus 로고    scopus 로고
    • Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract
    • Kobayashi KS, Chamaillard M, Ogura Y et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731-4.
    • (2005) Science , vol.307 , pp. 731-734
    • Kobayashi, K.S.1    Chamaillard, M.2    Ogura, Y.3
  • 48
    • 20244364236 scopus 로고    scopus 로고
    • Wnt signalling induces maturation of Paneth cells in intestinal crypts
    • van Es JH, Jay P, Gregorieff A et al. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol 2005; 7: 381-6.
    • (2005) Nat Cell Biol , vol.7 , pp. 381-386
    • van Es, J.H.1    Jay, P.2    Gregorieff, A.3
  • 49
    • 37349070287 scopus 로고    scopus 로고
    • The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4
    • Wehkamp J, Wang G, Kubler I et al. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 2007; 179: 3109-18.
    • (2007) J Immunol , vol.179 , pp. 3109-3118
    • Wehkamp, J.1    Wang, G.2    Kubler, I.3
  • 50
    • 84887212530 scopus 로고    scopus 로고
    • Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease
    • Koslowski MJ, Kubler I, Chamaillard M et al. Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS ONE 2009; 4: e4496.
    • (2009) PLoS ONE , vol.4
    • Koslowski, M.J.1    Kubler, I.2    Chamaillard, M.3
  • 51
    • 80051507729 scopus 로고    scopus 로고
    • From intestinal stem cells to inflammatory bowel diseases
    • Gersemann M, Stange EF, Wehkamp J. From intestinal stem cells to inflammatory bowel diseases. World J Gastroenterol 2003; 17: 3198-203.
    • (2003) World J Gastroenterol , vol.17 , pp. 3198-3203
    • Gersemann, M.1    Stange, E.F.2    Wehkamp, J.3
  • 52
    • 16844382886 scopus 로고    scopus 로고
    • Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease
    • Wehkamp J, Schmid M, Fellermann K, Stange EF. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J Leukoc Biol 2004; 77: 460-5.
    • (2004) J Leukoc Biol , vol.77 , pp. 460-465
    • Wehkamp, J.1    Schmid, M.2    Fellermann, K.3    Stange, E.F.4
  • 54
    • 0036270399 scopus 로고    scopus 로고
    • Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins
    • Wehkamp J, Schwind B, Herrlinger KR et al. Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins. Dig Dis Sci 2002; 47: 1349-55.
    • (2002) Dig Dis Sci , vol.47 , pp. 1349-1355
    • Wehkamp, J.1    Schwind, B.2    Herrlinger, K.R.3
  • 55
    • 77952683762 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
    • Peyrin-Biroulet L, Beisner J, Wang G et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A 2010; 107: 8772-7.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 8772-8777
    • Peyrin-Biroulet, L.1    Beisner, J.2    Wang, G.3
  • 56
    • 78751653584 scopus 로고    scopus 로고
    • Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1
    • Schroeder BO, Wu Z, Nuding S et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 2011; 469: 419-23.
    • (2011) Nature , vol.469 , pp. 419-423
    • Schroeder, B.O.1    Wu, Z.2    Nuding, S.3
  • 57
    • 0037234635 scopus 로고    scopus 로고
    • Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis
    • Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin Exp Immunol 2003; 131: 90-101.
    • (2003) Clin Exp Immunol , vol.131 , pp. 90-101
    • Fahlgren, A.1    Hammarstrom, S.2    Danielsson, A.3    Hammarstrom, M.L.4
  • 58
    • 0036318272 scopus 로고    scopus 로고
    • Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease
    • Wehkamp J, Fellermann K, Herrlinger KR et al. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002; 14: 745-52.
    • (2002) Eur J Gastroenterol Hepatol , vol.14 , pp. 745-752
    • Wehkamp, J.1    Fellermann, K.2    Herrlinger, K.R.3
  • 59
    • 0142026070 scopus 로고    scopus 로고
    • Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis
    • Wehkamp J, Harder J, Weichenthal M et al. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2003; 9: 215-23.
    • (2003) Inflamm Bowel Dis , vol.9 , pp. 215-223
    • Wehkamp, J.1    Harder, J.2    Weichenthal, M.3
  • 60
    • 33744493110 scopus 로고    scopus 로고
    • Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
    • Schauber J, Rieger D, Weiler F et al. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2006; 18: 615-21.
    • (2006) Eur J Gastroenterol Hepatol , vol.18 , pp. 615-621
    • Schauber, J.1    Rieger, D.2    Weiler, F.3
  • 61
    • 33947654353 scopus 로고    scopus 로고
    • Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease
    • Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. J Leukoc Biol 2007; 81: 907-15.
    • (2007) J Leukoc Biol , vol.81 , pp. 907-915
    • Schmid, M.1    Fellermann, K.2    Fritz, P.3    Wiedow, O.4    Stange, E.F.5    Wehkamp, J.6
  • 62
    • 34548130847 scopus 로고    scopus 로고
    • Reduced mucosal antimicrobial activity in Crohn's disease of the colon
    • Nuding S, Fellermann K, Wehkamp J, Stange EF. Reduced mucosal antimicrobial activity in Crohn's disease of the colon. Gut 2007; 56: 1240-7.
    • (2007) Gut , vol.56 , pp. 1240-1247
    • Nuding, S.1    Fellermann, K.2    Wehkamp, J.3    Stange, E.F.4
  • 63
    • 0042387792 scopus 로고    scopus 로고
    • Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster
    • Hollox EJ, Armour JA, Barber JC. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 2003; 73: 591-600.
    • (2003) Am J Hum Genet , vol.73 , pp. 591-600
    • Hollox, E.J.1    Armour, J.A.2    Barber, J.C.3
  • 64
    • 33748558056 scopus 로고    scopus 로고
    • A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon
    • Fellermann K, Stange DE, Schaeffeler E et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006; 79: 439-48.
    • (2006) Am J Hum Genet , vol.79 , pp. 439-448
    • Fellermann, K.1    Stange, D.E.2    Schaeffeler, E.3
  • 65
    • 78649479154 scopus 로고    scopus 로고
    • Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease
    • Aldhous MC, Abu BS, Prescott NJ et al. Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease. Hum Mol Genet 2010; 19: 4930-8.
    • (2010) Hum Mol Genet , vol.19 , pp. 4930-4938
    • Aldhous, M.C.1    Abu, B.S.2    Prescott, N.J.3
  • 66
    • 76349096044 scopus 로고    scopus 로고
    • Association of higher DEFB4 genomic copy number with Crohn's disease
    • Bentley RW, Pearson J, Gearry RB et al. Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol 2010; 105: 354-9.
    • (2010) Am J Gastroenterol , vol.105 , pp. 354-359
    • Bentley, R.W.1    Pearson, J.2    Gearry, R.B.3
  • 68
    • 34249945094 scopus 로고    scopus 로고
    • Defensins and other antimicrobial peptides in inflammatory bowel disease
    • Wehkamp J, Schmid M, Stange EF. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol 2007; 23: 370-8.
    • (2007) Curr Opin Gastroenterol , vol.23 , pp. 370-378
    • Wehkamp, J.1    Schmid, M.2    Stange, E.F.3
  • 69
    • 0025023631 scopus 로고
    • Mucin depletion in inflammatory bowel disease
    • McCormick DA, Horton LW, Mee AS. Mucin depletion in inflammatory bowel disease. J Clin Pathol 1990; 43: 143-6.
    • (1990) J Clin Pathol , vol.43 , pp. 143-146
    • McCormick, D.A.1    Horton, L.W.2    Mee, A.S.3
  • 70
    • 0028265506 scopus 로고
    • Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis
    • Pullan RD, Thomas GA, Rhodes M et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 1994; 35: 353-9.
    • (1994) Gut , vol.35 , pp. 353-359
    • Pullan, R.D.1    Thomas, G.A.2    Rhodes, M.3
  • 71
    • 0030875131 scopus 로고    scopus 로고
    • Colonic mucus and ulcerative colitis
    • Rhodes JM. Colonic mucus and ulcerative colitis. Gut 1997; 40: 807-8.
    • (1997) Gut , vol.40 , pp. 807-808
    • Rhodes, J.M.1
  • 72
    • 0034994474 scopus 로고    scopus 로고
    • Microbial modulation of innate defense: goblet cells and the intestinal mucus layer
    • Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr 2001; 73: 1131S-41S.
    • (2001) Am J Clin Nutr , vol.73
    • Deplancke, B.1    Gaskins, H.R.2
  • 73
    • 0030737814 scopus 로고    scopus 로고
    • Histochemistry of the surface mucous gel layer of the human colon
    • Matsuo K, Ota H, Akamatsu T, Sugiyama A, Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon. Gut 1997; 40: 782-9.
    • (1997) Gut , vol.40 , pp. 782-789
    • Matsuo, K.1    Ota, H.2    Akamatsu, T.3    Sugiyama, A.4    Katsuyama, T.5
  • 74
    • 0036340041 scopus 로고    scopus 로고
    • The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon
    • Katz JP, Perreault N, Goldstein BG et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 2002; 129: 2619-28.
    • (2002) Development , vol.129 , pp. 2619-2628
    • Katz, J.P.1    Perreault, N.2    Goldstein, B.G.3
  • 75
    • 0035824487 scopus 로고    scopus 로고
    • Requirement of Math1 for secretory cell lineage commitment in the mouse intestine
    • Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001; 294: 2155-8.
    • (2001) Science , vol.294 , pp. 2155-2158
    • Yang, Q.1    Bermingham, N.A.2    Finegold, M.J.3    Zoghbi, H.Y.4
  • 76
    • 60549086579 scopus 로고    scopus 로고
    • Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis
    • Gersemann M, Becker S, Kubler I et al. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. Differentiation 2009; 77: 84-94.
    • (2009) Differentiation , vol.77 , pp. 84-94
    • Gersemann, M.1    Becker, S.2    Kubler, I.3
  • 77
    • 79956306866 scopus 로고    scopus 로고
    • Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis
    • Zheng X, Tsuchiya K, Okamoto R et al. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis. Inflamm Bowel Dis 2011; 17: 2251-60.
    • (2011) Inflamm Bowel Dis , vol.17 , pp. 2251-2260
    • Zheng, X.1    Tsuchiya, K.2    Okamoto, R.3
  • 78
    • 0033057385 scopus 로고    scopus 로고
    • Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core
    • Hanski C, Born M, Foss HD et al. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core. J Pathol 1999; 188: 304-11.
    • (1999) J Pathol , vol.188 , pp. 304-311
    • Hanski, C.1    Born, M.2    Foss, H.D.3
  • 80
    • 0032985868 scopus 로고    scopus 로고
    • Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis
    • Van Klinken BJ, van der Wal JW, Einerhand AW, Buller HA, Dekker J. Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut 1999; 44: 387-93.
    • (1999) Gut , vol.44 , pp. 387-393
    • Van Klinken, B.J.1    van der Wal, J.W.2    Einerhand, A.W.3    Buller, H.A.4    Dekker, J.5
  • 81
    • 41349088375 scopus 로고    scopus 로고
    • Risk factors for opportunistic infections in patients with inflammatory bowel disease
    • Toruner M, Loftus Jr EV, Harmsen WS et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008; 134: 929-36.
    • (2008) Gastroenterology , vol.134 , pp. 929-936
    • Toruner, M.1    Loftus Jr., E.V.2    Harmsen, W.S.3
  • 82
    • 38749095183 scopus 로고    scopus 로고
    • European evidence-based consensus on the management of ulcerative colitis: current management
    • Travis SP, Stange EF, Lemann M et al. European evidence-based consensus on the management of ulcerative colitis: current management. J Crohns Colitis 2008; 2: 24-62.
    • (2008) J Crohns Colitis , vol.2 , pp. 24-62
    • Travis, S.P.1    Stange, E.F.2    Lemann, M.3
  • 83
    • 34248399194 scopus 로고    scopus 로고
    • Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin
    • Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, Fellermann K. Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun 2007; 75: 2399-407.
    • (2007) Infect Immun , vol.75 , pp. 2399-2407
    • Schlee, M.1    Wehkamp, J.2    Altenhoefer, A.3    Oelschlaeger, T.A.4    Stange, E.F.5    Fellermann, K.6
  • 84
    • 33646884826 scopus 로고    scopus 로고
    • Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
    • Prantera C, Lochs H, Campieri M et al. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther 2006; 23: 1117-25.
    • (2006) Aliment Pharmacol Ther , vol.23 , pp. 1117-1125
    • Prantera, C.1    Lochs, H.2    Campieri, M.3
  • 85
    • 0029079279 scopus 로고
    • Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection
    • Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 1617-21.
    • (1995) Gastroenterology , vol.108 , pp. 1617-1621
    • Rutgeerts, P.1    Hiele, M.2    Geboes, K.3
  • 87
    • 77957886834 scopus 로고    scopus 로고
    • Phosphatidylcholine (lecithin) and the mucus layer: evidence of therapeutic efficacy in ulcerative colitis?
    • Stremmel W, Hanemann A, Ehehalt R, Karner M, Braun A. Phosphatidylcholine (lecithin) and the mucus layer: evidence of therapeutic efficacy in ulcerative colitis? Dig Dis 2010; 28: 490-6.
    • (2010) Dig Dis , vol.28 , pp. 490-496
    • Stremmel, W.1    Hanemann, A.2    Ehehalt, R.3    Karner, M.4    Braun, A.5
  • 88
    • 21044457089 scopus 로고    scopus 로고
    • Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
    • Stremmel W, Merle U, Zahn A, Autschbach F, Hinz U, Ehehalt R. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut 2005; 54: 966-71.
    • (2005) Gut , vol.54 , pp. 966-971
    • Stremmel, W.1    Merle, U.2    Zahn, A.3    Autschbach, F.4    Hinz, U.5    Ehehalt, R.6
  • 89
    • 38449107095 scopus 로고    scopus 로고
    • Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial
    • Stremmel W, Ehehalt R, Autschbach F, Karner M. Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial. Ann Intern Med 2007; 147: 603-10.
    • (2007) Ann Intern Med , vol.147 , pp. 603-610
    • Stremmel, W.1    Ehehalt, R.2    Autschbach, F.3    Karner, M.4
  • 90
    • 78649505795 scopus 로고    scopus 로고
    • Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis - a review of three clinical trials
    • Stremmel W, Hanemann A, Braun A et al. Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis - a review of three clinical trials. Expert Opin Investig Drugs 2010; 19: 1623-30.
    • (2010) Expert Opin Investig Drugs , vol.19 , pp. 1623-1630
    • Stremmel, W.1    Hanemann, A.2    Braun, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.